Fig. 3From: Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinomaHigh expression of STON1 indicated a better outcome in KIRC patients. Kaplan–Meier curves of overall survival according to high and low expression of STON1 in TCGA data in KIRC patients by exploring the OncoLnc database (A), Kaplan–Meier database (B), and GEPIA2 database (C)Back to article page